logo
logo

Catalyst Clinical Research Announces The Acquisition Of Genpro Research

Jul 20, 2023almost 2 years ago

Acquiring Company

Catalyst Clinical Research

Acquired Company

Genpro Research

WilmingtonBiotechnologyMachine LearningArtificial IntelligenceBiotechnologyHealth Care

Description

Catalyst Clinical Research ("Catalyst"), an industry-leading provider of specialized clinical development solutions, announced today it has acquired Genpro Research ("Genpro"), a Massachusetts-based global clinical research organization with staff in the US, India, and Ireland.

Company Information

Company

Catalyst Clinical Research

Location

Wilmington, North Carolina, United States

About

Catalyst Clinical Research, a clinical research organization (CRO), provides highly customizable solutions to the global biopharmaceutical and biotechnology industries through two established solutions: Catalyst Oncology and Catalyst Flex. Catalyst Oncology provides full-service specialty oncology CRO offerings while Catalyst Flex delivers multi-therapeutic customer- or Catalyst-managed functional (FSP) services. With more than 1,000 staff and several offices in the United States, Europe, and the Asia-Pacific region, Catalyst's flexible service model is built from more than a decade of listening to customers, devising customer-centric solutions, and helping customers advance their clinical studies by leveraging expert teams and innovative technologies.

DealWatch™ Score

81
High M&A Activity

M&A Opportunity Analysis

Get personalized insights on M&A opportunities

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Related People

Kristin hidden

hidden
hidden

Nik hidden